Related Experiment Video
Updated: Jul 15, 2026
08:17
A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
Published on: August 15, 2019
Platelet glycoprotein Ib alpha supports experimental lung metastasis
Shashank Jain1, Masahiko Zuka, Jungling Liu
1Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Summary
Platelet glycoprotein (GP) Ib-IX is crucial for hemostasis and thrombosis. Its absence significantly reduces experimental metastasis, suggesting a role in tumor malignancy.
Area of Science:
- Hematology
- Oncology
- Vascular Biology
Background:
- Platelets play a key role in hemostasis and thrombosis via receptors like glycoprotein (GP) Ib-IX.
- Emerging evidence suggests platelets contribute to tumorigenesis and inflammation beyond their traditional roles.
- The GP Ib-IX receptor is critical for platelet tethering to thrombogenic surfaces.
Purpose of the Study:
- To investigate the role of platelet GP Ib-IX in experimental metastasis.
- To determine if GP Ib-IX function in hemostasis/thrombosis is relevant to tumor metastasis.
Main Methods:
- Established congenic (N10) mouse colonies with dysfunctional GP Ib-IX receptors.
- Utilized syngeneic mouse models of experimental metastasis with B16F10.1 melanoma cells.
Main Results:
- A functional absence of GP Ib-IX correlated with a 15-fold reduction in lung metastatic foci.
- The extracellular domain of the alpha-subunit of GP Ib was identified as the key component contributing to metastasis.
- Results support GP Ib-IX's dual role in hemostasis/thrombosis and tumor malignancy.
Conclusions:
- Platelet GP Ib-IX significantly contributes to experimental metastasis.
- The findings suggest that platelet functions in hemostasis and thrombosis are also involved in tumor progression.
